Jean George
QuietNamed in filings at Lightstone VenturesOn the current fund
- Board seats filed
- 7
Named in filings at Lightstone VenturesOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Cyteir Therapeutics | Biotech & pharma | January 2018 | Lightstone Singapore |
| Gemini Therapeutics | Biotech & pharma | April 2016 | Atlas Venture, Caduceus Capital, Lightstone Singapore, Orbimed Asia Partners, Orbimed Genesis |
| Thrasos Innovation | Biotech & pharma | March 2015 | Lightstone Singapore |
| HYDRA BIOSCIENCES | Biotech & pharma | March 2015 | Abingworth Bioventures, Lightstone Singapore |
| CATABASIS PHARMACEUTICALS | Biotech & pharma | March 2015 | Clarus, Lightstone Singapore, SV Life Sciences, Virtuoso-mccarran |
| Calithera Biosciences | Biotech & pharma | July 2014 | Lightstone Singapore |
| ACCELERON PHARMA | Healthcare services | December 2011 | Caduceus Capital, Lightstone Singapore, Orbimed Asia Partners, Orbimed Genesis, Polaris Partners |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Jean George on the board, based on 7 filed seats with a verified or cited source.